Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Background: This randomized controlled study sought to determine the effect of intermittent fasting on anthropometric measurements, fibroblast growth factor (FGF)-21, and autophagy markers, as well as on hepatic steatosis and fibrosis levels in overweight or obese patients with metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: Patients were randomly assigned into two groups: received a dietary treatment involving 22–25 kcal/kg/day of energy for 8 weeks and followed the same dietary intervention and a 16:8 pattern. The extent of hepatic steatosis and fibrosis was determined using transient elastography on a FibroScan® device. The controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), determined by transient elastography, reflect hepatic steatosis and fibrosis, respectively. In duplicate, serum levels of FGF-21, Beclin-1, and ATG-5 were determined using enzyme-linked immunosorbent assay. Results: The study included 48 patients with a mean age of 48.2 ± 1.4 years (27 female and 21 male). Improvements in anthropometric measurement and CAP and LSM levels and a decrease in serum FGF-21 levels were found in both groups (p < 0.05). Changes in the CAP and FGF-21 levels were higher in the energy + time-restricted diet group (p < 0.05). Autophagy-related protein (ATG)-5 levels increased only in the energy + time-restricted diet group [(0.74 (0.46–1.29) ng/mL vs. 0.95 (0.73–1.32) ng/mL, p = 0.03]. Conclusions: Intermittent fasting was potentially practical in the management of MAFLD. In particular, changes in FGF-21 and ATG-5 levels indicate the potential of intermittent fasting to regulate metabolic processes and autophagy. However, methodological limitations should be taken into consideration when interpreting the study results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Seven trials found no significant between-group differences in energy intake during the intervention (21, 24, 25), in change from baseline (16, 18, 25), or in post-intervention energy intake (20, 22), whereas two studies reported lower caloric intake in the IF groups than in the CER groups (23, 24).”
From Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Eight trials employed a parallel-group design (16, 18–24), and one utilized a crossover design (25).”
From Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis (2026) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · cited 2×
“The diets The diets were planned based on current guidelines, manuals, systematic reviews, and meta-analyses published in recent years on MAFLD [6,7,31]. were planned based on current guidelines, manuals, systematic reviews, and meta-analyses published in recent years on MAFLD [6,7,31].”
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472 · cited 2×
“…type 2 diabetes mellitus (T2DM), or underweight or normal weight with at least two metabolic risk abnormalities [waist circumference, blood pressure, triglycerides, high-density lipoprotein cholesterol (HDL-C), prediabetes, insulin resistance, high-sensitivity C reactive protein (CRP)] [29].”
Self-citationFGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125 · cited 2×
“Endogenous FGF-21 has been shown to facilitate insulin-independent glucose uptake in adipocytes and promote lipolysis, which reduces fat storage [25,26].”
Hatori, M., Vollmers, C., Zarrinpar, A., DiTacchio, L., Bushong, E. A., Gill, S., Leblanc, M., Chaix, A., Joens, M., Fitzpatrick, J. A. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.019 · Cited by 1,986 · cited 1×
“Thus, the intermittent fasting protocol has been hypothesized to be a potentially effective intervention in MAFLD [13–15].”
Sutton, E. F., Beyl, R., Early, K. S., Cefalu, W. T., Ravussin, E., & Peterson, C. M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.010 · Cited by 1,531 · cited 1×
“This pattern can positively affect metabolic health by supporting circadian rhythm [9].”
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504 · cited 1×
“Endogenous FGF-21 has been shown to facilitate insulin-independent glucose uptake in adipocytes and promote lipolysis, which reduces fat storage [25,26].”
Impact of intermittent fasting on health and disease processes
Mattson, M. P., Longo, V. D., & Harvie, M. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.10.005 · Cited by 1,187 · cited 1×
“One of the mechanisms by which intermittent fasting counteracts disease processes is the activation of cellular stress response signaling pathways that stimulate autophagy [16].”
TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop
Settembre, C., De Cegli, R., Mansueto, G., Saha, P. K., Vetrini, F., Visvikis, O., Huynh, T., Carissimo, A., Palmer, D., Jürgen Klisch, T., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2718 · Cited by 1,022 · cited 1×
“In recent years, increasing evidence suggests that autophagy is regulated during eating– starving cycles under physiological conditions [17,18].”
Zhang, X., Yeung, D. C. Y., Karpisek, M., Stejskal, D., Zhou, Z.-G., Liu, F., Wong, R. L. C., Chow, W.-S., Tso, A. W. K., Lam, K. S. L., et al. (2008) · Diabetes · doi:10.2337/db07-1476 · Cited by 908 · cited 1×
“In clinical studies, elevated serum levels of FGF-21 have been associated with obesity, metabolic syndrome, and diabetes [23], which are components of MAFLD.”
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO) (2016) · Diabetologia · doi:10.1007/s00125-016-3902-y · Cited by 683
Determination of reliability criteria for liver stiffness evaluation by transient elastography
Boursier, J., Zarski, J.-P., de Ledinghen, V., Rousselet, M.-C., Sturm, N., Lebail, B., Fouchard-Hubert, I., Gallois, Y., Oberti, F., Bertrais, S., et al. (2013) · Hepatology · doi:10.1002/hep.25993 · Cited by 662 · cited 1×
“A reliable measurement was defined as having at least ten valid measurements with an interquartile range–median ratio ≤ 0.3 [33].”
InfluentialGabel, K., Hoddy, K. K., Haggerty, N., Song, J., Kroeger, C. M., Trepanowski, J. F., Panda, S., & Varady, K. A. (2018) · Nutrition and Healthy Aging · doi:10.3233/nha-170036 · Cited by 626 · cited 1×
“In particular, the 16/8 model was found to be more sustainable compared to other intermittent fasting protocols and was evaluated as a potential strategy for managing diseases such as obesity, metabolic syndrome, and MAFLD [11,12].”
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Dushay, J., Chui, P. C., Gopalakrishnan, G. S., Varela–Rey, M., Crawley, M., Fisher, F. M., Badman, M. K., Martinez–Chantar, M. L., & Maratos–Flier, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.054 · Cited by 607
Cienfuegos, S., Gabel, K., Kalam, F., Ezpeleta, M., Wiseman, E., Pavlou, V., Lin, S., Oliveira, M. L., & Varady, K. A. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.018 · Cited by 597 · cited 1×
“In particular, the 16/8 model was found to be more sustainable compared to other intermittent fasting protocols and was evaluated as a potential strategy for managing diseases such as obesity, metabolic syndrome, and MAFLD [11,12].”
Nutrient-sensing nuclear receptors coordinate autophagy
Lee, J. M., Wagner, M., Xiao, R., Kim, K. H., Feng, D., Lazar, M. A., & Moore, D. D. (2014) · Nature · doi:10.1038/nature13961 · Cited by 518 · cited 1×
“In recent years, increasing evidence suggests that autophagy is regulated during eating– starving cycles under physiological conditions [17,18].”
The starvation hormone, fibroblast growth factor-21, extends lifespan in mice
Zhang, Y., Xie, Y., Berglund, E. D., Coate, K. C., He, T. T., Katafuchi, T., Xiao, G., Potthoff, M. J., Wei, W., Wan, Y., et al. (2012) · eLife · doi:10.7554/elife.00065 · Cited by 420 · cited 2×
“Because the FGF-21 molecule has a circadian rhythm disrupted by a high-fat diet, intermittent fasting has been claimed to have the benefit of rebalancing FGF-21 release and, thus, potentially preventing obesity [49].”
INTERMITTENT FASTING AND HUMAN METABOLIC HEALTH
Patterson, R. E., Laughlin, G. A., LaCroix, A. Z., Hartman, S. J., Natarajan, L., Senger, C. M., Martínez, M. E., Villaseñor, A., Sears, D. D., Marinac, C. R., et al. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2015.02.018 · Cited by 390 · cited 1×
“Cortisol and melatonin are key hormonal markers of circadian rhythm [58].”
Effects of intermittent fasting on body composition and clinical health markers in humans
Tinsley, G. M., & La Bounty, P. M. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv041 · Cited by 382 · cited 2×
“Moreover, assuming the role of autophagic dysfunction in the pathogenesis of MAFLD, intermittent fasting emerges as an even more interesting technique, as it is considered to stimulate autophagy [10].”
Liu, J., Ayada, I., Zhang, X., Wang, L., Li, Y., Wen, T., Ma, Z., Bruno, M. J., de Knegt, R. J., Cao, W., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.02.030 · Cited by 242 · cited 1×
“Metabolic dysfunction-associated fatty liver disease (MAFLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is characterized by fat deposition in the liver, is associated with obesity, diabetes, hypertension, and dyslipidemia, and continues to increase in prevalence [1].”
The role of nutrition in non‐alcoholic fatty liver disease: Pathophysiology and management
Berná, G., & Romero‐Gomez, M. (2020) · Liver International · doi:10.1111/liv.14360 · Cited by 235 · cited 1×
“While weight loss remains the most effective treatment for MAFLD, the relationship between dietary components and MAFLD has recently drawn increasing interest [64].”
Byun, S., Seok, S., Kim, Y.-C., Zhang, Y., Yau, P., Iwamori, N., Xu, H. E., Ma, J., Kemper, B., & Kemper, J. K. (2020) · Nature Communications · doi:10.1038/s41467-020-14384-z · Cited by 219 · cited 3×
“A recent study in mice showed that overnight fasting increases the expression of autophagy-related genes, including autophagy-related protein (ATG)-7, and regulates hepatic autophagy-mediated lipid metabolism [21].”
InfluentialVancells Lujan, P., Viñas Esmel, E., & Sacanella Meseguer, E. (2021) · Nutrients · doi:10.3390/nu13051442 · Cited by 209 · cited 1×
“…which contain beneficial phytochemicals, micronutrients, and fibers that provide long-term satiety and healthy gut microbiota, and the fact that none of the patients consumed > 50 g of fructose per day, which has been reported to have no detrimental effect on lipid and glucose control [67,68].”
Health implications of fructose consumption: A review of recent data
Rizkalla, S. W. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-82 · Cited by 202 · cited 1×
“…which contain beneficial phytochemicals, micronutrients, and fibers that provide long-term satiety and healthy gut microbiota, and the fact that none of the patients consumed > 50 g of fructose per day, which has been reported to have no detrimental effect on lipid and glucose control [67,68].”
Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
Yilmaz, Y., Eren, F., Yonal, O., Kurt, R., Aktas, B., Celikel, C. A., Ozdogan, O., Imeryuz, N., Kalayci, C., & Avsar, E. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02338.x · Cited by 195
Self-citationAre there outcome differences between NAFLD and metabolic‐associated fatty liver disease?
Younossi, Z. M., Paik, J. M., Al Shabeeb, R., Golabi, P., Younossi, I., & Henry, L. (2022) · Hepatology · doi:10.1002/hep.32499 · Cited by 182 · cited 1×
“Low awareness, gaps and failures in treatment, and increasing prevalence make MAFLD a significant public health problem [3].”
Ullah, R., Rauf, N., Nabi, G., Ullah, H., Shen, Y., Zhou, Y., & Fu, J. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.30121 · Cited by 172 · cited 1×
“Different dietary components influence the progression and development of MAFLD, and nutrition’s role in treating MAFLD has been extensively studied [5].”
Zhang, N., Liu, X., Xie, L. H., Shen, X., & Wu, J. (2019) · Laboratory Investigation · doi:10.1038/s41374-018-0177-6 · Cited by 166
A.S.P.E.N. Clinical Guidelines: Nutrition Support of Hospitalized Adult Patients With Obesity
Choban, P., Dickerson, R., Malone, A., Worthington, P., Compher, C., & and the American Society for Parenteral and Enteral Nutrition (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113499374 · Cited by 164
Meng, H., Zhu, L., Kord-Varkaneh, H., O Santos, H., Tinsley, G. M., & Fu, P. (2020) · Nutrition · doi:10.1016/j.nut.2020.110801 · Cited by 146 · cited 1×
“In contrast, HDL-C concentrations were not affected [62].”
A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD
Moore, M. P., Cunningham, R. P., Dashek, R. J., Mucinski, J. M., & Rector, R. S. (2020) · Obesity · doi:10.1002/oby.22964 · Cited by 128 · cited 2×
“Time-restricted eating (16/8) is one of the most used and tested fasting protocols [8].”
Clinical applications of transient elastography
Jung, K. S., & Kim, S. U. (2012) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2012.18.2.163 · Cited by 125 · cited 1×
“Hepatic steatosis and fibrosis were defined using controlled attenuation parameters (CAPs) and LSM. LSM measurement ranged between 2.5 and 75 kPa, and the CAP measurement, which indicates steatosis, ranged between 100 and 400 dB/m [34].”
InfluentialRickenbacher, A., Jang, J. H., Limani, P., Ungethüm, U., Lehmann, K., Oberkofler, C. E., Weber, A., Graf, R., Humar, B., & Clavien, P. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.010 · Cited by 114 · cited 1×
“These findings indicate that the FGF-21 molecule may be beneficial in treating MAFLD through its autophagic action [52].”
Eslamparast, T., Tandon, P., & Raman, M. (2017) · Nutrients · doi:10.3390/nu9080800 · Cited by 108 · cited 1×
“The diets The diets were planned based on current guidelines, manuals, systematic reviews, and meta-analyses published in recent years on MAFLD [6,7,31]. were planned based on current guidelines, manuals, systematic reviews, and meta-analyses published in recent years on MAFLD [6,7,31].”
Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease
Elias, M. C., Parise, E. R., de Carvalho, L., Szejnfeld, D., & Netto, J. P. (2009) · Nutrition · doi:10.1016/j.nut.2009.09.001 · Cited by 100 · cited 1×
“The importance of reduction in visceral obesity, which is directly related to the severity of MAFLD, should be emphasized in weight loss and improvements in anthropometric parameters [35].”
Barb, D., Bril, F., Kalavalapalli, S., & Cusi, K. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02414 · Cited by 100 · cited 1×
“In contrast, other authors have reported similar FGF-21 levels in groups with different severity levels of steatosis [42], inflammation, and fibrosis [43,44].”
Autophagy and Protein Secretion
Cavalli, G., & Cenci, S. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.015 · Cited by 97 · cited 1×
“ATG genes now appear to play a role in the underlying pathways, leading to the emergence of the concept of secretory autophagy [56].”
Krawczyk, M., Maciejewska, D., Ryterska, K., Czerwińka-Rogowska, M., Jamioł-Milc, D., Skonieczna-Żydecka, K., Milkiewicz, P., Raszeja-Wyszomirska, J., & Stachowska, E. (2018) · Nutrients · doi:10.3390/nu10111793 · Cited by 96 · cited 1×
“In addition, increased dietary fiber is beneficial in managing MAFLD by regulating intestinal permeability and protective effects against insulin resistance [65,66].”
Giannini, C., Feldstein, A. E., Santoro, N., Kim, G., Kursawe, R., Pierpont, B., & Caprio, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1250 · Cited by 95 · cited 1×
“Most imaging-based studies have shown a positive correlation between FGF-21 concentrations and liver fat content [39,41].”
The role of FGF21 and its analogs on liver associated diseases
Falamarzi, K., Malekpour, M., Tafti, M. F., Azarpira, N., Behboodi, M., & Zarei, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.967375 · Cited by 94 · cited 1×
“FGF-21 has recently drawn increasing interest as a therapeutic target for obesity-related metabolic disorders, including MAFLD, mainly because of its effect on lipid and carbohydrate metabolism [38,39].”
Koda, M., Kawakami, M., Murawaki, Y., & Senda, M. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2107-z · Cited by 92 · cited 2×
“Weight loss, focusing on reducing visceral fat, was accompanied by improvements in parameters associated with the severity of hepatic steatosis, inflammation, and fibrosis in patients with MAFLD [36].”
Crujeiras, A. B., Gómez-Arbeláez, D., Zulet, M. Á., Carreira, M. C., Sajoux, I., de Luis, D. A., Castro, A. I., Baltar, J., de la Torre, I. B., Sueiro, A. M., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.138 · Cited by 87 · cited 1×
“Low-energy and very low-energy ketogenic diet regimens had no difference in FGF-21 levels [45].”
Enríquez Guerrero, A., San Mauro Martín, I., Garicano Vilar, E., & Camina Martín, M. A. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-00821-1 · Cited by 75 · cited 1×
“These metabolic processes can lead to an improvement in plasma lipid concentration as well as weight loss [63].”
FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy
Zhu, S., Wu, Y., Ye, X., Ma, L., Qi, J., Yu, D., Wei, Y., Lin, G., Ren, G., & Li, D. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2774-2 · Cited by 74 · cited 1×
“Zhu et al. (2016) [50] demonstrated that FGF-21 can improve multiple metabolic parameters involved in the pathogenesis of MAFLD by promoting autophagy [50].”
Kouroumalis, E., Voumvouraki, A., Augoustaki, A., & Samonakis, D. N. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i1.6 · Cited by 70 · cited 1×
“High-fat diets in mice induce MAFLD, block hepatic autophagy, and lead to oxidative stress and mitochondrial dysfunction [19].”
The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism
Cuevas-Ramos, D., Almeda-Valdes, P., Aguilar-Salinas, C., Cuevas-Ramos, G., Cuevas-Sosa, A., & Gomez-Perez, F. (2009) · Current Diabetes Reviews · doi:10.2174/157339909789804396 · Cited by 67 · cited 1×
“FGF-21 has been identified as a key regulator of glucose, lipids, and overall energy balance [24].”
Yilmaz, Y. N., Yılmaz, N., Ateşž, F., Karakaya, F., Gökcan, H., Kaya, E., Adalı, G., Kartal, A., Şen, İ., Ahıshalı, E., et al. (2021) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2021.2020.0033 · Cited by 59 · cited 1×
“MAFLD is seen in approximately one-quarter of the adult population and has a prevalence of 45.5% in Turkey; it poses a substantial economic burden on the healthcare systems across the world [2].”
InfluentialSelf-citationSerum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure
Mutanen, A., Heikkilä, P., Lohi, J., Raivio, T., Jalanko, H., & Pakarinen, M. P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.003 · Cited by 55 · cited 1×
“In contrast, other authors have reported similar FGF-21 levels in groups with different severity levels of steatosis [42], inflammation, and fibrosis [43,44].”
Chawla, S., Beretoulis, S., Deere, A., & Radenkovic, D. (2021) · Nutrients · doi:10.3390/nu13082525 · Cited by 52 · cited 1×
“Elevated melatonin during food intake may impair insulin secretion and glucose tolerance, suggesting that avoiding eating 2–3 h before sleep could offer metabolic benefits [59].”
Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease
Raptis, D. D., Mantzoros, C. S., & Pοlyzos, S. A. (2023) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s352008 · Cited by 47 · cited 4×
“Most observational studies have reported elevated hep-atic or circulating levels of FGF-21 in patients with MAFLD [39,40].”
InfluentialFeehan, J., Mack, A., Tuck, C., Tchongue, J., Holt, D. Q., Sievert, W., Moore, G. T., de Courten, B., & Hodge, A. (2023) · Nutrients · doi:10.3390/nu15234870 · Cited by 47 · cited 1×
“…improving visceral adiposity and steatosis compared with standard care and found a higher decrease in CAP values in the intermittent fasting group (n = 10) than in the standard care group (n = 13) and no significant difference in LSM values within and between the groups compared with baseline [37].”
Zhao, L., Hutchison, A. T., Liu, B., Wittert, G., Thompson, C. H., Nguyen, L., Au, J., Vincent, A. D., Manoogian, E. N. C., Le, H. D., et al. (2022) · Obesity · doi:10.1002/oby.23499 · Cited by 45 · cited 1×
“Early TRF, such as skipping dinner, may improve sleep through reduced nighttime cortisol and enhance alertness with higher morning levels [60].”
Influence of intermittent fasting on autophagy in the liver
Ma, Y., Jiang, X., Tang, W., & Song, P. (2023) · BioScience Trends · doi:10.5582/bst.2023.01207 · Cited by 40 · cited 1×
“FGF-21 can also induce autophagy by promoting SIRT1 expression [51].”
Kim, K. E., Shin, H. J., Ju, Y., Jung, Y., An, H. S., Lee, S. J., Jeong, E. A., Lee, J., Hwang, G., & Roh, G. S. (2023) · Nutrients · doi:10.3390/nu15214574 · Cited by 33
Saleh, S. A. K., Santos, H. O., Găman, M., Cerqueira, H. S. C., Zaher, E. A., Alromaih, W. R., Arafat, N. S., Adi, A. R., Adly, H. M., Alyoubi, R. A., et al. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.11.009 · Cited by 32
Asghari, S., Rezaei, M., Rafraf, M., Taghizadeh, M., Jafarabadi, M. A., & Ebadi, M. (2022) · Nutrients · doi:10.3390/nu14122509 · Cited by 31 · cited 1×
“Further, a randomized controlled study on overweight and obese individuals with MAFLD reported that an energy-restricted diet affected neither circulating FGF-21 levels nor MAFLD [46].”
Xiao, Q., Bauer, C., Layne, T. M., & Playdon, M. C. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00715-z · Cited by 28 · cited 1×
“One study found that early evening fasting reduced obesity risk, while late evening fasting increased it [61].”
Tong, M., Zheng, Q. Y., Liu, M., Chen, L., Lin, Y., Tang, S., & Zhu, Y. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1897241 · Cited by 28 · cited 1×
“Reports suggesting that ATG-5 could be used as a therapeutic target in the treatment of liver fibrosis are mostly based on studies conducted in mice or cell cultures [53,54].”
Wang, Y.-Y., Tian, F., Qian, X.-L., Ying, H.-M., & Zhou, Z.-F. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1439473 · Cited by 28 · cited 1×
“The sample size was calculated using G*Power 3.1.9.7 software based on the expected difference in liver stiffness measurement (LSM) scores (approximately 1.03 kPa) and an estimated standard deviation of ~1.3 kPa [28].”
InfluentialAu, K., Zheng, M.-H., Lee, W., Ghanem, O. M., Mahawar, K. K., Shabbir, A., le Roux, C. W., Targher, G., Byrne, C. D., Yilmaz, Y., et al. (2024) · Current Obesity Reports · doi:10.1007/s13679-024-00582-z · Cited by 26 · cited 1×
“The approval of resmetirom, an oral, liver-targeted, thyroid hormone receptor beta-selective agonist, represents a promising therapeutic option for adults with moderate to advanced liver fibrosis [4].”
Self-citationFGF21-mediated autophagy: Remodeling the homeostasis in response to stress in liver diseases
Shen, W., Yang, M., Chen, H., He, C., Li, H., Yang, X., Zhuo, J., Lin, Z., Hu, Z., Lü, D., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.05.019 · Cited by 19
Waluga, M., Kukla, M., Żorniak, M., Kajor, M., Liszka, Ł., Dyaczyński, M., Kowalski, G. J., Zadlo, D., Waluga, E., Olczyk, P., et al. (2017) · PubMed · Cited by 14
Güveli, H., Kenger, E. B., Ozlu, T., Kaya, E., & Yilmaz, Y. (2021) · PubMed · doi:10.1097/meg.0000000000002110 · Cited by 10 · cited 2×
“A study investigating nutritional status in individuals with MAFLD (n = 106) found that saturated fatty acid intake was associated with advanced fibrosis levels [65].”
Self-citationCastillo, M. F., Salgado-Canales, D., Arrese, M. A., Francisco Barrera, M., & Mikhailidis, D. P. (2024) · Current Vascular Pharmacology · doi:10.2174/0115701611285401240110074530 · Cited by 9 · cited 1×
“Thus, the intermittent fasting protocol has been hypothesized to be a potentially effective intervention in MAFLD [13–15].”
Guerra, N. P., Leyens, K., Müller, L., Brauer, D., Janowitz, D., Schlick, S., Pilz, K., Grabe, H. J., Vollmar, B., & Kuhla, A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.935805 · Cited by 8 · cited 1×
“Recent data suggest intermittent fasting may affect obesity-induced FGF-21 resistance [48,49].”
Feehan, J., Mack, A., Tuck, C. J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2641051/v1 · Cited by 8
Kenger, E. B., Guveli, H., Ergün, C., Kaya, E., & Yilmaz, Y. (2020) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2020.0004 · Cited by 7 · cited 1×
“All Fibroscan measurements were performed following the manufacturer’s instructions as specified previously [32].”
Self-citationEl‐Hamd, M. A., Abdel‐Hamid, S., Hamdy, A.-T., & Abdelhamed, A. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03219-2 · Cited by 3 · cited 1×
“Among these proteins, ATG-5 plays a critical role in autophagic vesicle formation [57].”
El-Shayeb, A. F., Deghedy, A., Bedewy, E. E. D. S., Badawy, S., & Abdeen, N. S. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-021-00149-w · Cited by 2 · cited 1×
“As a result of this study, it was suggested that serum Beclin-1 and ATG-5 could serve as novel biomarkers for predicting the risk of hepatocellular carcinoma [55].”
Krasner, Y. A., Romanov, V. V., Fazullina, O. N., Осипенко, М. Ф., & Klimontov, V. V. (2024) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20230618 · Cited by 1
Cited by
Non-pharmacological treatment of MASLD
Dufour, J., & Berzigotti, A. (2026) · Diabetologia · doi:10.1007/s00125-026-06811-5 · Cited by 1
Li, H., & Li, T. (2026) · Frontiers in nutrition · doi:10.3389/fnut.2026.1833688 · Cited by 1
Alqahtani, H. A., & Aref, M. (2025) · Arab Journal of Basic and Applied Sciences · doi:10.1080/25765299.2025.2553434
“IF was potentially practical in the management of hepatic steatosis, inflammation, or fibrosis in fatty liver disease associated with metabolic dysfunction via reduction of fibroblast growth factor levels, regulation of metabolic processes and autophagy (Ozlu Karahan et al., 2025).”
Structural and Functional Characterization of the Mouse Liver during Intermittent Fasting
Dmitrieva, S. A., Giniyatullina, D. M., Vologin, D. S., & Ponomareva, A. A. (2026) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093026020079
Advances in Non-Alcoholic Fatty Liver Disease: Pathophysiology, Diagnosis, and Emerging Therapies
Katsaros, I., & Schizas, D. (2026) · Life · doi:10.3390/life16060915 · Cited by 1
“Whether examined through the lens of IBD-associated intestinal permeability, [4,5], the autophagic responses modulated by fasting cycles [6], or the microbial signatures associated with fibrosis and genetic susceptibility [8], dysbiosis and its downstream hep-atic consequences appear critical to…”
Metadata
- Authors
- Ozlu Karahan, T., Yilmaz Akyuz, E., Yilmaz Karadag, D., Yilmaz, Y., & Eren, F.
- Affiliations
- Department of Nutrition and Dietetics, Faculty of Health Sciences, Istanbul Bilgi University, Istanbul 34440, Turkey
- Department of Nutrition and Dietetics, Hamidiye Faculty of Health Sciences, University of Health Sciences, Istanbul 34668, Turkey
- Institute of Gastroenterology, Marmara University, Istanbul 34854, Turkey
- Recep Tayyip Erdoğan University (TR)
- Corresponding author
- Eren, Fatih
- Venue
- Life
- Publisher
- MDPI AG
- Published
- 2025-04-25
- Volume
- 15
- Issue
- 5
- Pages
- 696
- ISSN
- 2075-1729 (ISSN-L)
- PMC
- PMC12113254
- OpenAlex
- W4409781467
- Cited by
- 9
- References
- 69
- Citations by year
- 2026: 8 · 2025: 1
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Life (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Health Institutes of Türkiye (TUSEB) (24172, 02025002003275)
- Recep Tayyip Erdoğan University Development Foundation (24172, 02025002003275)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- intermittent fasting, non-alcoholic fatty liver disease, hepatic steatosis, liver fibrosis, FGF21, autophagy, ATG5, Beclin-1, time-restricted eating, hypocaloric diet, obesity, transient elastography, controlled attenuation parameter, liver stiffness measurement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.